News
17
November
2023
Primo wins 2023 TAIPEI Prominent Enterprise Award
21
July
2023
Primo Biotechnology Raises Over 6.5 Million USD in Funding, Pioneering an International-level Radiopharmaceutical Manufacturing Facility
1
July
2022
Dr. Chi-Wei Chang joins Primo as CTO of Radiopharmaceutical Chemistry.
1
May
2022
Tackle Cancer Challenge
May 1 – May 15, 2022
18
NOV
2021
Are Asian Countries Ready for Novel Radiopharmaceuticals?
15
NOV
2021
Dr. Ya-Yao Huang Act as an Ambassador of Oncidium